Non-Ergot Dopamine Agonists Do Not Increase the Risk of Heart Failure in Parkinson’s Disease Patients: A Meta-Analysis of Randomized Controlled Trials
Journal of Clinical Medicine Research
doi 10.14740/jocmr2541e
Full Text
Abstract
Available in
Date
January 1, 2016
Authors
Publisher
Elmer Press, Inc.